ORGANIC
LETTERS
2
004
Vol. 6, No. 18
083-3085
Total Synthesis of Cystothiazoles
A and B
3
Jian Shao and James S. Panek*
Department of Chemistry and Center for Chemical Methodology and
Library DeVelopment, Boston UniVersity, 590 Commonwealth AVenue,
Boston, Massachusetts 02215
Received June 11, 2004
ABSTRACT
Convergent enantioselective syntheses of the antifungal agents cystothiazoles A and B are described. The routes feature an asymmetric
crotylation using a propargylic dicobalt hexacarbonyl complex, which provided enhanced diastereoselectivity over the uncomplexed propargylic
acetal. The bisthiazole fragment was united with the side chain through a Stille cross-coupling of a terminal (E)-vinylstannane with a 4-trifloyl-
substituted thiazole.
In 1998, Sakagami and co-workers reported the isolation of
cystothiazoles A and B from a culture broth of the myxo-
bacterium, Cystobacter fuscus. Cystothiazoles A and B have
Our retrosynthetic strategy is illustrated in Scheme 1. The
target molecules could be divided into two subunits, C -C
fragment 4 and bisthiazole fragment 5, which will be coupled
1
7
1
demonstrated potent antifungal activity against a wide range
of fungi. These agents, however, show little or no effect on
inhibition of bacterial growth. Although these compounds
are structurally related to the known antibiotic myxothiazole,
cystothiazole A is more active against fungi and less
cytotoxic.
at a late stage via a Stille cross-coupling reaction. The
C
1
-C fragment could be obtained from the â-ketoester 6,
7
which was ultimately derived from a crotylsilane addition
to the dicobalt hexacarbonyl complex 10. The bisthiazole
fragment 5 was synthesized by a regioselective Stille cross-
coupling reaction with the 2,4-bistrifloyl thiazole 7 and
2
4
Earlier reports have documented the independent total
4-bromothiazole 8.
3
synthesis of cystothiazoles A, B, C, E and G. In this paper,
In our preliminary studies, it was found that the direct
we describe convergent enantioselective syntheses of cys-
tothiazoles A and B.
crotylation between silane (S)-9 and the 3-(trimethylsilyl)
(1) (a) Ojika, M.; Suzuki, Y.; Tsukamoto, A.; Sakagami, Y.; Fudou, R.;
Yoshimura, T.; Yamanaka, S. J. Antibiot. 1998, 51, 275-281. (b) Suzuki,
Y.; Ojika, M.; Sakagami, Y.; Fudou, R.; Yamanka, S. Tetrahedron 1998,
5
4, 11399-11404.
2) (a) Gerth, K.; Irschik, H.; Reichenbach, H.; Trowitzsch, W. J. Antibiot.
980, 33, 1474-1479. (b) Trowitzsh, W.; Reifenstahl, G.; Wray, W.; Gerth,
(
1
K. J. Antibiot. 1980, 33, 1480-1490.
3) (a) Williams, D.; Patnaik, S.; Clark, M. J. Org. Chem. 2001, 66,
463-8469. (b) Kato, K.; Nishimura, A.; Yamamoto, Y.; Akita, H.
(
8
Tetrahedron Lett. 2002, 43, 643-645. (c) Kato, K.; Sasaki, T.; Takayama
H.; Akita, H. Tetrahedron 2003, 59, 2679-2685. (d) DeRoy, P.; Charette,
A. Org. Lett. 2003, 5, 4163-4165. (e) Bach, T.; Heuser, S. Angew. Chem.,
Int. Ed. 2001, 40, 3184-3185. (f) Sasaki, T.; Kato, K.; Akita, H. Chem.
Pharm. Bull. 2004, 52, 770-771. (g) Akita, H.; Sasaki, T.; Kato K.; Suzuki
Y.; Kondo, K.; Sakagami, Y.; Ojika, M.; Fudou R.; Yamanaka, S.
Tetrahedron 2004, 60, 4735-4738.
(
4) Langille, N. F.; Dakin, L. A.; Panek, J. S. Org. Lett. 2002, 4, 2485-
2
488.
1
0.1021/ol048893d CCC: $27.50 © 2004 American Chemical Society
Published on Web 07/30/2004